A detailed history of Laurel Wealth Advisors, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Laurel Wealth Advisors, Inc. holds 3,847 shares of ZTS stock, worth $680,765. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,847
Previous 3,925 1.99%
Holding current value
$680,765
Previous $582,000 3.09%
% of portfolio
0.06%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $10,228 - $12,282
-78 Reduced 1.99%
3,847 $564,000
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $8,007 - $9,857
-54 Reduced 1.36%
3,925 $582,000
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $92,958 - $119,253
-596 Reduced 13.03%
3,979 $684,000
Q1 2022

May 13, 2022

SELL
$181.39 - $234.03 $376,747 - $486,080
-2,077 Reduced 31.22%
4,575 $863,000
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $1.29 Million - $1.64 Million
6,652 New
6,652 $1.62 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Laurel Wealth Advisors, Inc. Portfolio

Follow Laurel Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.